Extensive experience in biological analysis using mass spectrometry. At Pfizer, I am developing mass spectrometry based methods to identify MHC class II presented peptides from monocyte derived dendritic cells for immunogenicity prediction of protein based therapeutics. Previously, at PerkinElmer, I developed mass spectrometry applications in the areas of food and drug analysis. My responsibilities there also included development and validation of quantitative clinical IVD assays.At Massachusetts General Hospital and Boston University Center for Biological Mass Spectrometry, I applied proteomics and lipid analytical techniques to improve understanding of antibiotic treatment resistant Lyme arthritis.Skills include: high resolution accurate mass and triple quadrupole mass spectrometry method development | nanoflow liquid chromatography | protein and metabolite database searching and validation | biological and biochemical techniques | biological sample preparation